iCoreExchange is hosted and managed entirely by iMedicor, eliminating the need for any IT involvement. iCoreExchange provides a streamlined and intuitive interface that will run in any modern browser, including IE, Chrome, Firefox and Safari. iMedicor Chief Technology Officer, Srini Vasan stated, "We are very excited about this entirely new platform that is both secure and HIPAA-Compliant. We believe the iCoreExchange platform is the most advanced set of communication tools available on the market. Our proprietary technology allows healthcare providers and patients to communicate both securely and efficiently within a single secure, managed, regulatory-compliant environment."
iCoreExchange allows healthcare providers and patients to send and receive secure and verified emails, attach files by dragging them into an easy-to-use "compose" window, all using NHIN Direct Protocol, as required by Meaningful Use Stage 2 federal regulation. Within the iCoreExchange, users can create private folders and search the public address book for providers to add to a secure, HIPAA-compliant practice network. The search can be by specialty, geography or affiliation. Healthcare professionals will also have the ability to communicate securely outside their immediate network.
iCoreExchange allows healthcare providers to network and build communities of peers to facilitate referrals, appointments and patient communication, all within the iCoreExchange. Robert McDermott, Chief Executive Officer of iMedicor stated, "We are very happy to bring the iCoreExchange's cutting edge platform capability to our customers and have it available for the entire healthcare community including patients and providers. We are confident that iCoreExchange will be well-received by the healthcare community. Indeed, early adoption is robust and accelerating as iMedicor reaches out to an increasing number of providers and institutions."
iMedicor would welcome the investment community to observe and ask us about upgrades to the iCoreExchange and new products as we introduce exciting new solutions to the market in the coming weeks and months.
ABOUT IMEDICOR
iMedicor is a national provider of secure, HIPAA-compliant communications solutions for the healthcare community. iMedicor offers physicians, patients and other healthcare providers the use of a secure, HIPAA-compliant communications network that addresses current federal standards for security and interoperability as defined by Meaningful Use regulations. iMedicor also serves as a leading national Meaningful Use consultancy that assists doctors and dentists convert from paper to electronic health records (EHRs) while qualifying under Meaningful Use Federal Incentive Funding guidelines.
Forward Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21 E of the Securities Exchange Act of 1934. All statements other than statements of historical facts included in this press release are forward-looking statements. These statements relate to future events or to the Company's future financial performance and involve known and unknown risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond the Company's control which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to operations, results of operations, growth strategy and liquidity. Such risks, uncertainties and other factors, which could impact the Company and the forward-looking statements contained herein are included in the Compan's filings with the Securities and Exchange Commission. Actual results could differ materially from those anticipated in these forward-looking statements.
For more information contact: John Schneller at iMedicor, 888-810-7706, ext. 822.
SOURCE: iMedicor